Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rxo (RXO) EPS (Weighted Average and Diluted) (2021 - 2025)

Rxo (RXO) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with -$0.27 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 1250.0% year-over-year to -$0.27, compared with a TTM value of -$0.59 through Dec 2025, up 70.79%, and an annual FY2025 reading of -$0.59, up 72.81% over the prior year.
  • EPS (Weighted Average and Diluted) was -$0.27 for Q4 2025 at Rxo, down from -$0.08 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.38 in Q2 2022 and bottomed at -$1.81 in Q3 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.09, with a median of -$0.03 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 125.0% in 2023, then plummeted 18000.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.36 in 2021, then crashed by 111.11% to -$0.04 in 2022, then skyrocketed by 125.0% to $0.01 in 2023, then tumbled by 300.0% to -$0.02 in 2024, then tumbled by 1250.0% to -$0.27 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for RXO at -$0.27 in Q4 2025, -$0.08 in Q3 2025, and -$0.06 in Q2 2025.